
    
      -  Dose-escalation stage : designed as classical 3+3 to determine MTD or RP2D to evaluate
           approximately GX-I7.

        -  Dose-expansion stage : designed to enroll additional 6-12 patients to acquire additional
           safety and pharmacodynamic data to more fully inform the dose selection for RP2D
    
  